NEW YORK (GenomeWeb News) – The Translational Genomics Research Institute will conduct bioinformatics-based research for the National Cancer Institute's Cancer Biomedical Informatics Grid (caBIG) network through a contract with SAIC-Frederick.
The contract, which makes TGen an In Silico Research Center of Excellence (ISRCE), provides $692,00 over the first 12 months and it includes two 12-month option periods, bringing the potential value of the agreement up to nearly $2.1 million over three years.
TGen will partner with informatics company 5AM Solutions in the project, which will involve analyzing genomic data from brain tumor models and targeted therapies in order to develop personalized treatment programs.
"This will be a very unique data set, representing the largest collection of patient brain tumor models and the widest variety of therapies applied in a controlled setting,'' Michael Berens, Head of TGen's Brain Tumor Research Lab, said in a statement. "We hope to create a process where a patient's tumor would align with one of these models, and we would know which of the 20 treatments was the best one against that tumor."
The tumor models the researchers will use were developed through the Ivy Genomics Based Medicine Project, conducted at TGen using a grant from the Ben and Catherine Ivey Foundation.
The goal of the ISRCE program is to promote in silico research using caBIG tools and data in order to add scientific value to the network's cancer data sets.